Diality Gains 510(k) Approval for Moda-fix System

Diality, a renal disease-focused medical device business located in Irvine, California, received 510(k) approval from the US FDA for their novel haemodialysis system for treating both acute and chronic renal failure.

The business’s Moda-flx system, which offers simple-to-use variable flow rate ranges, is intended to help medical professionals. It allows doctors to quickly tailor each haemodialysis session to the specific demands of every individual inside a single, integrated system, the business claims.

Once a medical device business want to commercially sell an innovative product, it has to receive the 510(k) marking at least ninety days in advance of launch.

Osman Khawar, M.D., CEO of Diality stated: “Receiving 510(k) clinical clearance for Moda-flx is an incredible milestone in our mission of developing solutions to improve lives impacted by kidney disease.”

They continued: “We believe this platform will represent a new paradigm in the treatment of kidney disease and will help reduce the burden of care for all kidney care stakeholders.”